17-8319526-C-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_173728.4(ARHGEF15):c.2297C>T(p.Ser766Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000646 in 1,610,512 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. S766S) has been classified as Benign.
Frequency
Consequence
NM_173728.4 missense
Scores
Clinical Significance
Conservation
Publications
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- schizophreniaInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ARHGEF15 | NM_173728.4 | c.2297C>T | p.Ser766Leu | missense_variant | Exon 15 of 16 | ENST00000361926.8 | NP_776089.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ARHGEF15 | ENST00000361926.8 | c.2297C>T | p.Ser766Leu | missense_variant | Exon 15 of 16 | 1 | NM_173728.4 | ENSP00000355026.3 | ||
| ARHGEF15 | ENST00000421050.2 | c.2297C>T | p.Ser766Leu | missense_variant | Exon 15 of 16 | 1 | ENSP00000412505.1 | |||
| ARHGEF15 | ENST00000647883.1 | c.1760C>T | p.Ser587Leu | missense_variant | Exon 12 of 13 | ENSP00000498197.1 | ||||
| ENSG00000226871 | ENST00000820533.1 | n.100-747G>A | intron_variant | Intron 1 of 3 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152234Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000323 AC: 8AN: 247672 AF XY: 0.0000448 show subpopulations
GnomAD4 exome AF: 0.0000624 AC: 91AN: 1458160Hom.: 0 Cov.: 31 AF XY: 0.0000565 AC XY: 41AN XY: 725320 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152352Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74512 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2297C>T (p.S766L) alteration is located in exon 15 (coding exon 14) of the ARHGEF15 gene. This alteration results from a C to T substitution at nucleotide position 2297, causing the serine (S) at amino acid position 766 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Developmental and epileptic encephalopathy Uncertain:1
This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 766 of the ARHGEF15 protein (p.Ser766Leu). This variant is present in population databases (rs200402507, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with ARHGEF15-related conditions. ClinVar contains an entry for this variant (Variation ID: 530479). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C15". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at